Back to dataset
UK Inflammatory Bowel Disease (IBD) audit: Round 4 (2012 - 2014)Data field description file paediatric biological therapies audit 2014
You're previewing the first 4 rows of this file.
Download this file| Column 1 | Column 2 | Column 3 | Column 4 | Column 5 | Column 6 | Column 7 | Column 8 | Column 9 |
|---|---|---|---|---|---|---|---|---|
| Health board / Trust name | Sitename | Number of patients with Crohn's disease entered at your site | Number of Crohn's disease follow-up treatments after initial infusion | Response to treatment | Remission achieved | Patients with Crohn's disease treated with Infliximab appropriately prescribed in compliance with NICE criterion1.5 (TA187) | Number of Crohn's disease patients with PROM data completed at initial treatment | Number of Crohn's disease patients with PROM data completed at follow-up treatment |
| Name of Health Board / Trust | Name of site | No of Crohn's disease patients entered | Number of Crohn's disease follow-up treatments after initial infusion | Percentage (%) of Crohn's disease patients with a PCDAI drop of >=15 at any follow up between 10 and 14 weeks | Percentage (%) of Crohn's disease patients with a PCDAI score of <=10 at any follow up between 10 and 14 weeks | Percentage of patients with Crohn's disease treated with Infliximab appropriately prescribed in compliance with NICE criterion1.5 (TA187) | Percentage of Crohn's disease patients with PROM data completed at initial treatment | Percentage of Crohn's disease patients with PROM data completed at follow-up treatment |
| text | text | integer | integer | Percentage (Integer) | Percentage (Integer) | Percentage (Integer) | Percentage (Integer) | Percentage (Integer) |
| text | text | integer | integer | 0% (0) | 0% (0) | 0% (0) | 0% (0) | 0% (0) |